View clinical trials related to Central Retinal Vein Occlusion.
Filter by:This randomized clinical trial is conducted to evaluate the effect of three intravitreal injections of bevasizumab versus two intravitreal injections of triamcinolone in acute central retinal vein occlusion. The outcomes are visual acuity and central macular thickness. The follow-up time is 6 months.
Treatment of macular edema secondary to central retinal vein occlusion is more effective with combined therapy of bevacizumab and triamcinolone than bevacizumab alone.
The ATORVO study is designed to determine whether atorvastatin (Lipitor) can improve vision, when compared to placebo